FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Alvogen Inc.)

View source ↗

Summary

FDA approved the original ANDA for lisdexamfetamine dimesylate (generic) from Alvogen, enabling a generic version of the ADHD and binge eating disorder treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)